"Chondrosarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)
| Descriptor ID |
D002813
|
| MeSH Number(s) |
C04.557.450.565.280 C04.557.450.795.300
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Chondrosarcoma".
Below are MeSH descriptors whose meaning is more specific than "Chondrosarcoma".
This graph shows the total number of publications written about "Chondrosarcoma" by people in this website by year, and whether "Chondrosarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 7 | 1 | 8 |
| 1996 | 0 | 1 | 1 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 3 | 4 |
| 1999 | 3 | 1 | 4 |
| 2000 | 3 | 2 | 5 |
| 2001 | 4 | 0 | 4 |
| 2002 | 2 | 0 | 2 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 3 | 1 | 4 |
| 2013 | 4 | 0 | 4 |
| 2014 | 3 | 1 | 4 |
| 2015 | 2 | 1 | 3 |
| 2016 | 5 | 1 | 6 |
| 2017 | 2 | 1 | 3 |
| 2018 | 2 | 1 | 3 |
| 2019 | 2 | 0 | 2 |
| 2020 | 5 | 0 | 5 |
| 2021 | 2 | 0 | 2 |
| 2022 | 3 | 0 | 3 |
| 2023 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chondrosarcoma" by people in Profiles.
-
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes. Clin Cancer Res. 2023 12 01; 29(23):4844-4852.
-
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery. J Neurooncol. 2023 Sep; 164(2):377-386.
-
Role of Apparent Diffusion Coefficient Map-Based First- and High-Order Radiomic Features for the Discrimination of Sacral Chordomas and Chondrosarcomas With Overlapping Conventional Imaging Features. JCO Precis Oncol. 2023 09; 7:e2300243.
-
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma. Clin Cancer Res. 2023 08 15; 29(16):2988-3003.
-
EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression. Elife. 2023 01 09; 12.
-
Patient, Disease, and Treatment-Related Factors Affecting Progression-Free and Disease-Specific Survival in Recurrent Chondrosarcomas of the Skull Base. Oper Neurosurg (Hagerstown). 2023 01 01; 24(1):33-43.
-
Dedifferentiated chondrosarcoma with minimal or small dedifferentiated component. Mod Pathol. 2022 07; 35(7):922-928.
-
Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol. 2022 03; 121:73-80.
-
Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma. Clin Cancer Res. 2021 12 01; 27(23):6543-6558.
-
Chondrosarcoma. J Am Acad Orthop Surg. 2021 07 01; 29(13):553-562.